Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eyvind Axelsen"'
Autor:
Arne Søraas, Karl Trygve Kalleberg, John Arne Dahl, Camilla Lund Søraas, Tor Åge Myklebust, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Mette S Istre, Eyrun F Kjetland, Giske Ursin
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256142 (2021)
Long-COVID-19 is a proposed syndrome negatively affecting the health of COVID-19 patients. We present data on self-rated health three to eight months after laboratory confirmed COVID-19 disease compared to a control group of SARS-CoV-2 negative patie
Externí odkaz:
https://doaj.org/article/e62b4db8401a40a389973e3aeb32d2a4
Autor:
Karl Trygve Kalleberg, Tor Åge Myklebust, Silje Bakken Jørgensen, Mette Istre, Giske Ursin, Arne Søraas, Eyvind Axelsen, Camilla Lund Søraas, Roar Bævre-Jensen, John Arne Dahl, Andreas Lind, Eyrun Floerecke Kjetland
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0256142 (2021)
PLoS ONE, Vol 16, Iss 8, p e0256142 (2021)
Long-COVID-19 is a proposed syndrome negatively affecting the health of COVID-19 patients. We present data on self-rated health three to eight months after laboratory confirmed COVID-19 disease compared to a control group of SARS-CoV-2 negative patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36d120f6adcc8a3429a9d3df9832672d
http://europepmc.org/articles/PMC8389372
http://europepmc.org/articles/PMC8389372
Autor:
Eyrun F. Kjetland, Karl Trygve Kalleberg, Camilla Lund Søraas, Bato Hammarström, Tor Åge Myklebust, Synne Jenum, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Frank Olav Pettersen, Lene B. Solberg, Cathrine Lund Hadley, Mette S. Istre, Knut Liestøl, John Arne Dahl, Giske Ursin, Arne Søraas
BackgroundThe risk factors for SARS-CoV-2 transmission are not well characterised in Western populations. We sought to identify potential risk factors for transmission and actionable information to prevent for SARS-CoV-2.MethodsIndividuals tested for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e65344e6597ecb9341182e4217bce38
https://doi.org/10.1101/2020.12.23.20248514
https://doi.org/10.1101/2020.12.23.20248514
Autor:
Søraas, Arne1 (AUTHOR) arne@meg.no, Kalleberg, Karl Trygve2 (AUTHOR), Dahl, John Arne1 (AUTHOR), Søraas, Camilla Lund3 (AUTHOR), Myklebust, Tor Åge4,5 (AUTHOR), Axelsen, Eyvind6 (AUTHOR), Lind, Andreas1 (AUTHOR), Bævre-Jensen, Roar7 (AUTHOR), Jørgensen, Silje Bakken8 (AUTHOR), Istre, Mette S.1 (AUTHOR), Kjetland, Eyrun F.1,9 (AUTHOR), Ursin, Giske5,10,11 (AUTHOR)
Publikováno v:
PLoS ONE. 8/26/2021, Vol. 16 Issue 8, p1-13. 13p.
Publikováno v:
Therapeutic Drug Monitoring; Oct2018, Vol. 40 Issue 5, p567-571, 5p
Autor:
Søraas, Arne, Bø, Ragnhild, Kalleberg, Karl Trygve, Støer, Nathalie C., Ellingjord-Dale, Merete, Landrø, Nils Inge
Publikováno v:
JAMA Network Open; 7/29/2021, Vol. 4 Issue 7, pe2118717-e2118717, 1p